FN1 and neoplasm: Experiments about TNBC indicated that W23–1006 covalently inhibits ALKBH5, increasing the m6A level of fibronectin 1 (FN1) mRNA, thereby reducing the expression of FN1 and bringing overall tumor suppression both in vivo and in vivo (193).